| Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate S Ouanes, M Rabl, C Clark, C Kirschbaum, J Popp Alzheimer's Research & Therapy 14 (1), 190, 2022 | 10 | 2022 |
| The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer’s disease C Clark, M Rabl, L Dayon, J Popp Frontiers in Aging Neuroscience 14, 1065904, 2022 | 10 | 2022 |
| Blood plasma protein profiles of neuropsychiatric symptoms and related cognitive decline in older people M Rabl, C Clark, L Dayon, GL Bowman, J Popp Journal of Neurochemistry 164 (2), 242-254, 2023 | 5 | 2023 |
| Neuropsychiatric symptoms in cognitive decline and Alzheimer’s disease: biomarker discovery using plasma proteomics M Rabl, C Clark, L Dayon, J Popp Journal of Neurology, Neurosurgery & Psychiatry, 2024 | | 2024 |
| Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression M Rabl, L Zullo, P Lewczuk, J Kornhuber, TK Karikari, K Blennow, ... Research Square, 2024 | | 2024 |
| Subjective cognitive impairment and biomarkers of Alzheimer’s disease L Zullo, B Fenix, M Rabl, C Clark, J Popp Alzheimer's & Dementia 19, e073025, 2023 | | 2023 |
| Blood and CSF proteome alterations, and regional brain volumetry patterns associated with neuropsychiatric symptoms in a memory clinic cohort M Rabl, C Clark, J Richiardi, B Maréchal, GL Bowman, L Dayon, J Popp Alzheimer's & Dementia 19, e072577, 2023 | | 2023 |
| Sex‐specific metabolomics‐derived blood biomarkers of Alzheimer’s disease. C Clark, E Laczko, M Rabl, S Stojkovic, J Popp Alzheimer's & Dementia 19, e079535, 2023 | | 2023 |
| Blood plasma profiles of neuropsychiatric symptoms in older people M Rabl, C Clark, L Dayon, GL Bowman, J Popp Alzheimer's & Dementia 18, e063376, 2022 | | 2022 |
| Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression M Rabl, L Zullo, P Lewczuk, J Kornhuber, TK Karikari, K Blennow, ... | | |
| Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression M Rabl, L Zullo, P Lewczuk, J Kornhuber, TK Karikari, K Blennow, ... | | |
| Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression M Rabl, L Zullo, P Lewczuk, J Kornhuber, TK Karikari, K Blennow, ... | | |
